Richard P. Blumberg - 10 Apr 2025 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role: Director, 10%+ Owner
Signature: /s/ Richard P. Blumberg
Issuer symbol: GTHP
Transactions as of: 10 Apr 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Sep 2025, 16:03:35 UTC
Previous filing: 24 Oct 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Blumberg Richard P.	Director, 10%+ Owner	5835 PEACHTREE CORNERS EAST, STE. B, PEACHTREE CORNERS	/s/ Richard P. Blumberg	04 Sep 2025	0001486345

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHP	Common Stock	Other		+165,481	+2.5%		6,855,206	10 Apr 2025	Direct	F1
transaction	GTHP	Common Stock	Other		+55,853	+0.81%		6,911,059	10 Apr 2025	Direct	F2
transaction	GTHP	Common Stock	Other		+81,121	+1.2%		6,992,180	21 Aug 2025	Direct	F4
transaction	GTHP	Preferred Series E Stock	Other		-233	-100%		0	21 Aug 2025	Direct	F5
transaction	GTHP	Common Stock	Other		+932,000	+13%		7,924,180	21 Aug 2025	Direct	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHP	Stock Options	Award	$0	+110,000		$0.000000	110,000	03 Jun 2025	Common Stock	110,000	$0.1400	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.
F2	These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.0943.
F3	One-fourth of the shares are subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028.
F4	These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.
F5	On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price.